NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Zhejiang Xinguang Pharmaceutical Co. Ltd (SHE: 300519)
300519 Technical Analysis
5
As on 1st Aug 2025 300519 STOCK Price closed @ 19.80 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 12.62 & Strong Buy for SHORT-TERM with Stoploss of 12.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300519STOCK Price
Open | 17.21 | Change | Price | % |
High | 20.36 | 1 Day | 2.24 | 12.76 |
Low | 17.10 | 1 Week | 3.86 | 24.22 |
Close | 19.80 | 1 Month | 5.96 | 43.06 |
Volume | 31125278 | 1 Year | 5.30 | 36.55 |
52 Week High 17.02 | 52 Week Low 9.73 |
SHE China Most Active Stocks
002131 | 3.90 | 1.83% |
002437 | 4.04 | 8.89% |
300058 | 7.18 | 3.31% |
002570 | 7.81 | 2.09% |
000813 | 4.70 | -3.09% |
300182 | 6.11 | 6.45% |
000725 | 4.03 | -0.25% |
000558 | 7.37 | 10.00% |
002097 | 14.19 | 7.09% |
002370 | 7.40 | 9.96% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300519 Daily Charts |
300519 Intraday Charts |
Whats New @ Bazaartrend |
300519 Free Analysis |
|
300519 Important Levels Intraday
RESISTANCE | 26.08 |
RESISTANCE | 24.07 |
RESISTANCE | 22.82 |
RESISTANCE | 21.58 |
SUPPORT | 18.02 |
SUPPORT | 16.78 |
SUPPORT | 15.53 |
SUPPORT | 13.52 |
300519 Forecast August 2025
4th UP Forecast | 32.34 |
3rd UP Forecast | 28.32 |
2nd UP Forecast | 25.83 |
1st UP Forecast | 23.35 |
1st DOWN Forecast | 16.25 |
2nd DOWN Forecast | 13.77 |
3rd DOWN Forecast | 11.28 |
4th DOWN Forecast | 7.26 |
300519 Weekly Forecast
4th UP Forecast | 28.14 |
3rd UP Forecast | 25.47 |
2nd UP Forecast | 23.81 |
1st UP Forecast | 22.16 |
1st DOWN Forecast | 17.44 |
2nd DOWN Forecast | 15.79 |
3rd DOWN Forecast | 14.13 |
4th DOWN Forecast | 11.46 |
300519 Forecast2025
4th UP Forecast | 42.75 |
3rd UP Forecast | 35.39 |
2nd UP Forecast | 30.84 |
1st UP Forecast | 26.29 |
1st DOWN Forecast | 13.31 |
2nd DOWN Forecast | 8.76 |
3rd DOWN Forecast | 4.21 |
4th DOWN Forecast | -3.15 |
Zhejiang Xinguang Pharmaceutical Co. Ltd ( SHE China Symbol : 300519 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300519 Other Details
Segment | EQ | |
Market Capital | 2342400000.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
300519 Address
![]() |
300519 Latest News
300519 Business Profile
Zhejiang Xinguang Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in China. The company offers pharmaceutical products in the areas of cardiovascular, orthopedics, health food, respiratory system, digestive system, and urinary system; and products for the removal of heat and toxic substances, as well as tonic and other products. It offers its products in the form of oral solution, troche, capsule, granule, syrup, and bulks. Zhejiang Xinguang Pharmaceutical Co., Ltd. was founded in 1970 and is based in Shengzhou, China. Address: No. 25, Huancheng West Road, Shengzhou, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service